Day: February 20, 2026

STEINHAUSEN, Switzerland, Feb. 19, 2026 (GLOBE NEWSWIRE) — Transocean Ltd. (NYSE: RIG) today reported financial results for the fourth quarter and full year of 2025. The Company will hold a conference call and webcast at 9 a.m. EST, 3 p.m. CET, on Friday, February 20, 2026, to discuss the results, with participation details included in this release. In addition, supplemental slides have been posted to the Investors section of the Company’s website at www.deepwater.com. 2025 KEY POINTSOperating revenues were $3.965 billion, up 13% from $3.524 billion in 2024. Revenue efficiency(1) was 96.5%, up from 94.5%. Net loss attributable to controlling interest was $2.915 billion, $3.04 per diluted share. Adjusted EBITDA of $1.37 billion, up from $1.148 billion or 19%. Cash flows from operations were $749 million, up $302 million or 68%. Free...

MELBOURNE, Australia and INDIANAPOLIS, Feb. 20, 2026 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces its financial results for the year ended December 31, 2025. FY 2025 key results1 Group performance2: Double-digit revenue growth and positive adjusted operating cash flowRevenue of US$803.8 million, up by 56%3 and achieving upsized full year guidance4. US$157.1 million invested in research and development (R&D) product development for late-stage therapeutics and precision medicine pipeline assets5, in line with stated FY 2025 guidance. Adjusted EBITDA6 of US$39.5 million, reflective of increased operating expenditure driven by strategic acquisitions, investment in commercial infrastructure and research and development (R&D). A non-material loss before tax...